QIAGEN N.V. (NASDAQ:QGEN)

CAPS Rating: 4 out of 5

The Company is a provider of innovative technologies and products for preanalytical sample preparation and linked molecular assay solutions.

Recs

1
Player Avatar DrLinks (< 20) Submitted: 7/20/2013 11:26:53 PM : Outperform Start Price: $20.38 QGEN Score: -2.47

MYGN's only competitor in molecular diagnostics

Featured Broker Partners


Advertisement